ORM1 Antikörper (C-Term)
Kurzübersicht für ORM1 Antikörper (C-Term) (ABIN453240)
Target
Alle ORM1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- This antibody reacts to Alpha-1-acid glycoprotein 1.
-
Aufreinigung
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human ORM1
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ORM1 (Orosomucoid 1 (ORM1))
-
Andere Bezeichnung
- ORM1 / AGP1
-
Hintergrund
- ORM1 is a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. The specific function of this protein has not yet been determined, however, it may be involved in aspects of immunosuppression.Synonyms: Alpha-1-acid glycoprotein 1, OMD1, Orosomucoid-1
-
Gen-ID
- 5004
-
NCBI Accession
- NP_000598
-
UniProt
- P02763
-
Pathways
- Response to Growth Hormone Stimulus
Target
-